ClinicalTrials.Veeva

Menu

Slow Digestible Carbohydrates and Exercise in Adolescents with Type 1 Diabetes

University at Buffalo (UB) logo

University at Buffalo (UB)

Status

Active, not recruiting

Conditions

Hypoglycemia
Type 1 Diabetes

Treatments

Dietary Supplement: super starch
Dietary Supplement: maltodextrin

Study type

Interventional

Funder types

Other

Identifiers

NCT05540132
SS_T1D_2022

Details and patient eligibility

About

In this within-subject cross-over study, the investigators hypothesize that corn-starch based supplements taken prior to exercise will decrease the risk of delayed hypoglycemia in adolescents with T1D, improve performance during exercise, and decrease glycemic variability during exercise.

Full description

Type 1 diabetes (T1D), one of the most common chronic diseases in adolescents, is caused by the destruction of insulin producing beta cells which are located in the pancreas. There are many factors that impact diabetes control which are insulin administration, intake of food and exercise. When an individual exercises, weight is better managed which allows for a better cardiovascular system. Exercising also improves insulin sensitivity which can increased the risk for delayed hypoglycemia (low blood sugar). Many individuals with T1D do not participate (or under-participate) in exercise due to the fear of hypoglycemia. This study will recruit adolescents with Type 1 diabetes to undergo a maximal exercise test to determine their VO2max. Study participants then will complete 2 exercise performance tests prior to which the participant will be randomized to consume 22 grams of either fast acting carbohydrates or long-acting cornstarch based supplements. Subjects will be asked to bike for 45 minutes (at 50% of VO2max) and then complete a 3.75 mile bike ride as quickly as possible. The investigators will document the time to completion of the bike ride as well as monitor glucose levels via continuous glucose monitoring for 12 hours after completion of the exercise test.

Enrollment

20 estimated patients

Sex

All

Ages

12 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 12 - <18 year old male and female subjects with Type 1 diabetes for > 1 year
  • HbA1c <10.5%
  • Body Mass Index >10th % and <95th%
  • Not being treated with sensor-augmented pump therapy
  • Ability to participate in exercise activity - biking
  • Willing to wear a continuous glucose monitor (CGM) sensor

Exclusion criteria

  • Severe hypoglycemia (requiring glucagon or external assistance) in last 6 months
  • Admission for diabetic ketoacidosis in last 3 months
  • History of chronic lung disease, congenital heart disease or chronic asthma
  • Food (including corn)/dye allergies
  • Other chronic medical conditions except for well-controlled thyroid disease

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

20 participants in 2 patient groups

Fast Acting Carbohydrate
Active Comparator group
Description:
Prior to exercise performance test, subject will be randomized to consume 22 grams of fast-acting carbohydrate (maltodextrin) or slow-acting cornstarch based supplement
Treatment:
Dietary Supplement: maltodextrin
Slow-acting cornstarch supplement
Active Comparator group
Description:
Prior to exercise performance test, subject will be randomized to consume 22 grams of slow-acting cornstarch based supplement or fast-acting carbohydrate (maltodextrin)
Treatment:
Dietary Supplement: super starch

Trial contacts and locations

1

Loading...

Central trial contact

Amanda House, RN,MPH; Lucy D Mastrandrea, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems